BCTX
Briacell Therapeutics
BCTX
BCTX
18 hedge funds and large institutions have $17M invested in Briacell Therapeutics in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
5% less capital invested
Capital invested by funds: $17.9M → $17M (-$861K)
5% less funds holding
Funds holding: 19 → 18 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
18
Holding in Top 10
1
Calls
$3.99M
Puts
$43K
Top Buyers
| 1 | +$207K | |
| 2 | +$196K | |
| 3 | +$156K | |
| 4 |
Morgan Stanley
New York
|
+$123K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$103K |
Top Sellers
| 1 | -$615K | |
| 2 | -$409K | |
| 3 | -$253K | |
| 4 |
Belvedere Trading
Chicago,
Illinois
|
-$30.7K |
| 5 |
CWP
Concord Wealth Partners
Abingdon,
Virginia
|
-$28.1K |